These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 7858823)
1. Use of botulinum toxin to alleviate facial pain. Girdler NM Br J Hosp Med; 1994 Oct 5-18; 52(7):363. PubMed ID: 7858823 [No Abstract] [Full Text] [Related]
2. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Song PC; Schwartz J; Blitzer A Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205 [TBL] [Abstract][Full Text] [Related]
3. The use of botulinum toxin for the treatment of temporomandibular disorder. Freund B; Schwartz M Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334 [No Abstract] [Full Text] [Related]
4. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature. Jeynes LC; Gauci CA Pain Pract; 2008; 8(4):269-76. PubMed ID: 18503628 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. Awan KH; Patil S; Alamir AWH; Maddur N; Arakeri G; Carrozzo M; Brennan PA J Oral Pathol Med; 2019 Mar; 48(3):192-200. PubMed ID: 30604895 [TBL] [Abstract][Full Text] [Related]
6. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin efficacy for the treatment of pain. Acquadro MA; Borodic GE J Clin Anesth; 2005 Aug; 17(5):328-30. PubMed ID: 16102679 [No Abstract] [Full Text] [Related]
10. A new indication of botulinum toxin: leiomyoma-related pain. Onder M; Adişen E J Am Acad Dermatol; 2009 Feb; 60(2):325-8. PubMed ID: 19150277 [TBL] [Abstract][Full Text] [Related]
11. The use of botulinum toxin type A for the treatment of facial spasm. Serrano LA Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446 [TBL] [Abstract][Full Text] [Related]
12. Periorbital pain associated with hemifacial spasms that responded to botulinum toxin treatment and microvascular decompression surgery: a case report. Iida H; Sumi K; Takenaka M; Asano T; Matsumoto S; Iwama T; Dohi S J Clin Anesth; 2005 Aug; 17(5):363-5. PubMed ID: 16102687 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of hemifacial spasm with botulinum toxin]. Tanaka M; Hakuto T; Akatsuka M; Morimoto E; Hama T; Morimoto M; Hiraga Y; Hyodo M Masui; 1993 Jun; 42(6):883-7. PubMed ID: 8320807 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin-A for the treatment of hemifacial spasm. Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735 [TBL] [Abstract][Full Text] [Related]
18. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Greene PE; Fahn S Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in otolaryngology: a review of its actions and opportunities for use. Neuenschwander MC; Pribitkin EA; Sataloff RT Ear Nose Throat J; 2000 Oct; 79(10):788-9, 792, 794 passim. PubMed ID: 11055100 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-physiology and applications in head and neck disorders. Keir J Head Neck; 2005 Jun; 27(6):525-35. PubMed ID: 15898076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]